Eli Lilly and Company Introduces Insulin Value Program in Response to COVID-19 Crisis

As a consequence of the COVID-19 global health crisis, the U.S. is going through rough times economically speaking. There is an enormous amount of people that have lost their jobs, and no one should struggle with paying their medications. This is why Eli Lilly and Company is introducing the Lilly Insulin Value Program. Diabetic patients with or without commercial insurance may benefit from this program and be able to fill their monthly insulin prescriptions of Lilly insulin for $35. The Lilly Insulin Value Program is effective since April 7th and covers most insulins including all Humalog formulations.

Patients can get the savings by calling the Lilly Diabetes Solution Center at (833) 808-1234 from 8am-8pm (EST) Monday through Friday. Representatives are willing to help patients get the card either through e-mail (within 24-hours) or through the U.S. mail. It is important to mention, that patients who already own a co-pay card from Lilly Diabetes Solution Center with a higher co-pay, can also benefit from this program since the cards have been re-set to a $35 co-pay.

Last but not least, representatives can also direct people to affordability options to lower their existing out-of-pocket costs further, including free insulin for people with minimal to no income. As per federal guidelines, seniors with Medicare Part D plans are not eligible to get this card. Yet such beneficiaries can still contact the Solutions Center for eligibility on other options that include receiving donated insulin for people with lower incomes or even discounted insulin products.

For further details on insulin products, purpose, safety, and patient information click here.


References

investor.lilly.com. New 35 Co-Pay Now Available Through Lilly Insulin Value Program. https://investor.lilly.com/news-releases/news-release-details/new-35-co-pay-now-available-through-lilly-insulin-value-program (accessed 2020 9 Apr)

lilly.com. Amid COVID-19 Lilly Introduces 35 Dollar Copay Insulin. https://www.lilly.com/news/stories/covid19-crisis-lilly-introduces-35-dollar-copay-insulin (accessed 2020 9 Apr)